Date:
17th September, 2024

Time:
2pm (CET)

Location:
Online (via Zoom)

Discussed subjects during the Webinar:

• Align your R&D efforts with patient needs and payer priorities.

• Build a compelling value proposition.

• Navigate complex regulatory and reimbursement landscapes.

• Increase the probability of commercial success.

Presented by:

Dr. Sanja Fitzgerald

She is an experienced strategic market access, pricing, and reimbursement advisor for the pharmaceutical industry. Holding a PhD in Chemistry from ETH Zurich, Sanja’s 15-year career trajectory spans both product development, innovation and commercial leadership within the biotech industry.

With a decade of hands-on experience in R&D, Sanja transitioned seamlessly into client-facing roles in innovation and commercial functions. This unique blend of scientific acumen and business acumen positions her as a valuable asset for pharmaceutical and biotech companies navigating complex market landscapes.
Sanja’s expertise in crafting and executing global market access strategies extends to conducting rigorous risk/opportunity assessments for investors and in-licensing partners, as well as providing strategic guidance to biotech startups and due diligence support to investors. With a particular emphasis on oncology and rare diseases, she bridges the gap between regulatory hurdles and market access imperatives.

Sanja’s impressive track record includes leading successful market access, pricing, and reimbursement projects. Her commitment to professional development is reflected in her RAPS Pharma Regulatory Affairs and IPMA Project Management certifications.